Dorthe Hartwell

Dorthe Hartwell

Auto-generated profile, based on publicly available information

Dorthe Hartwell

Department of Gynaecology and Obstetrics, Rigshospitalet, Copenhagen University Hospital , Copenhagen

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2026 in European Heart Journal
Verified
Journal Article
Closed access
HRHelene Vistisen Ryde
Helene Vistisen Ryde
MRMarie S Reinert
Marie S Reinert
DHDorthe Hartwell
Dorthe Hartwell
CECharlotte Ekelund
Charlotte Ekelund
LKLars Valeur Köber
Lars Valeur Köber
EHEva Havers-Borgersen
Eva Havers-Borgersen
Background and Aims: Endometriosis affects ∼10% of women of reproductive age. Emerging evidence suggests a link between endometriosis and systemic inflammation, potentially increasing the risk of venous thromboembolism (VTE), yet data on the association between endometriosis and VTE are lacking. The aim was to examine the association between endometriosis and long-term risk of VTE. Methods: A nationwide, registry-based cohort study including all women with endometriosis from 1977 to 2024, matched 1:4 on birth and index year with women from the background population without endometriosis. The primary outcome was VTE as a composite of deep venous thrombosis and pulmonary embolism, while the individual components comprised the secondary outcomes. Results: The study included 63 999 women with endometriosis and 255 996 matched female controls. At baseline, women with endometriosis had a higher burden of comorbidities, had greater use of medications, and more often had a history of abdominal/gynaecological surgeries. The incidence rate of VTE was higher in women with endometriosis [2.18 per 1000 person-years; 95% confidence interval (CI) 2.10–2.26] compared with controls (1.54 per 1000 person-years; 95% CI 1.51–1.58). In Cox regression analyses, endometriosis was associated with a significantly increased risk of VTE, even after adjustment for relevant comorbidities and use of hormonal contraception [unadjusted hazard ratio (HR) 1.43; 95% CI 1.36–1.50 and adjusted HR 1.52; 95% CI 1.42–1.63]. Similar results were observed for VTE subgroups: deep venous thrombosis alone (adjusted HR 1.50; 95% CI 1.38–1.63) and pulmonary embolism alone (adjusted HR 1.52; 95% CI 1.36–1.70). Conclusions: Endometriosis was associated with an increased long-term risk of VTE compared with a matched background population. These findings highlight the importance of clinical awareness and consideration of thrombotic risk in women with a history of endometriosis.

14 October 2025 in Human Reproduction
Verified
Journal Article
Closed access
RLRoos Leroy
Roos Leroy
JAJason Anthony Abbott
Jason Anthony Abbott
NBNadia Benahmed
Nadia Benahmed
CCCécile Camberlin
Cécile Camberlin
MJMats De Jaeger
Mats De Jaeger
FDFabian Desimpel
Fabian Desimpel
STUDY QUESTION: How is endometriosis care organized at the primary, secondary, and tertiary care levels in five high-income countries? SUMMARY ANSWER: In all countries under study, initiatives have been taken to provide endometriosis care by experienced health care professionals in a multidisciplinary setting, but certification criteria for secondary and tertiary centres vary greatly across countries. WHAT IS KNOWN ALREADY: Endometriosis is a highly prevalent and complex disease with potentially significant physical, sexual, psychological, social, and economic impacts on those affected. Logically, a multidisciplinary approach by health care providers with expertise and experience has been recommended. STUDY DESIGN, SIZE, DURATION: This study included five high-income countries where endometriosis care was centralized to some extent or where a national action plan for endometriosis was developed. PARTICIPANTS/MATERIALS, SETTING, METHODS: Based on a review of the literature, five countries were selected: Australia, Denmark, Germany, the Netherlands, and the UK. Information was collected through a review of peer-reviewed and grey literature that was revised and amended by experts from each country. MAIN RESULTS AND THE ROLE OF CHANCE: In 2018, Australia launched a comprehensive government-led national action plan for endometriosis. In Germany, secondary and tertiary endometriosis care is organized at three levels, while in Denmark and the Netherlands, a two-level system has been installed, whereas in the UK, only tertiary referral centres have been initiated to date. Only in Denmark must secondary care centres refer patients with advanced endometriosis to tertiary care centres. In all countries studied, treatment for advanced endometriosis is also carried out in centres without certification, where the quality of care is not assessed. National endometriosis registries have commenced and are active in Australia and the UK. In the selected countries, various initiatives have been taken to enhance the training of health care professionals, to inform patients, and to increase awareness on endometriosis. In none of the studied countries is endometriosis (automatically) recognized and/or registered as a chronic condition. LIMITATIONS, REASONS FOR CAUTION: In the five countries evaluated, there are continuing efforts to further improve the organization of endometriosis care. With ongoing revisions of service provision, resourcing and health care structures for endometriosis are evolving considerably; therefore, this overview should be considered as a snapshot taken up to early 2025. Since this overview relies principally on scientific literature, policy documents, and expert opinions, and not on objective outcomes, there may be dyssynchrony between what is summarized here and actual clinical practice. WIDER IMPLICATIONS OF THE FINDINGS: This overview may provide advice and guidance for policy makers in the development of a framework for the organization of endometriosis care in their country. STUDY FUNDING/COMPETING INTEREST(S): The research was supported by the government-approved work program of the Belgian Health Care Knowledge Centre (KCE). C.N. is funded though the NECST Network grant (4-I66SNMA) from the Australian Government Department of Health and Aged Care, manages research grant funding from the MRFF, is Chair of the Australian Clinical Trials Alliance (ACTA) Special Interest Group for Network Managers (SIGNet) and was a previous employee with CSL Vifor (formerly Vifor Pharma Pty. Ltd). J.A. is on advisory boards and received consulting fees from Gedeon Richter, BD and Hologic, received honoraria for lectures from MSD and Hologic, and received support for attending meetings from Hologic. He is on the Endometriosis Advisory Group for the Australian Government, Chaired the first Australian Guidelines for Endometriosis Diagnosis and Management, and contributed to the Governments National Action Plan on Endometriosis. He is the Chair of the NECST Network, past-President of AGES, and past-Chair and Medical Director of Endometriosis Australia and holds multiple competitive grants in endometriosis research through Australian Government funding agencies (Commonwealth Department of Health and Aged Care, MRFF), AGES, Country Women’s Association of NSW, MSD and Endometriosis Australia. R.L., N.B., C.C., F.D., M.D.J., D.H., A.K., A.N., S.O., and K.-W.S. have no conflicts of interest to declare. TRIAL REGISTRATION NUMBER: N/A.